Dsicover a recent study that compared Stockholm3 with other established biomarkers for prostate cancer screening. Learn more.

Prostate cancer is one of the most common types of cancer that affects men. Understanding what it is, who is at risk and how ...

Prostate cancer remains one of the most significant health concerns for men worldwide, with detection and treatment options ...

A man who discovered he had prostate cancer following a free blood test run by a volunteer group has urged other men to get ...

It is well known that men are reluctant to see a doctor, especially a urologist. As a result, there is a risk that prostate ...

Discover comprehensive insights into approved therapeutics and research developments targeting Prostate-Specific Membrane Antigen (PSMA). This product provides detailed competitor analysis, R&D stages ...

A new study provides the strongest evidence to date on the clinical utility of a polygenic score for prostate cancer ...

Metastatic castration-resistant prostate cancer causes urinary symptoms, fatigue, pain, and more. This article covers the ...

The first patient has been enrolled in a trial evaluating ClarityDX Prostate’s impact on early prostate cancer detection, ...

In 2021, just over a third of men ages 55 to 69 had had a PSA (prostate-specific antigen) blood test to check for prostate cancer in the past year. That ...

A group of senior gym-goers who got their prostates checked at roughly the same time were shocked to find almost half of them ...